Levamisole Ameliorates Rheumatoid Arthritis by Downregulating the PI3K/Akt Pathway in SD Rats

• Main Authors: Mu Guo (Author), Xiangbin Yu (Author), Zesheng Yang (Author), Hanlu Zheng (Author), Jiahui Zhang (Author), Junxiang Wang (Author), Yiqi Liao (Author), Weirui Huang (Author), Zhaolong Lin (Author), Yingxue Yan (Author), Nengfu Qiu (Author), Jianmin Chen (Author), Yue Yu (Author)
• Format: Book
• Published: MDPI AG, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background/Objectives:</b> Rheumatoid arthritis (RA) is a systemic chronic autoimmune disease characterized by a protracted course, high rates of morbidity, and disability yet lacks effective therapeutic modalities. Levamisole (LVM), an immunomodulatory drug, has been clinically repor...